Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-19

Clinical Trial Update: Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

View source ↗

Summary

Non-interventional study evaluating alogliptin and alogliptin fixed-dose combinations with pioglitazone or metformin in standard clinical practice; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin (alogliptin)
  • PIOGLITAZONE (Pioglitazone)
  • alogliptin fixed-dose combinations with metformin (alogliptin with metformin)
  • alogliptin fixed-dose combinations with pioglitazone (alogliptin with pioglitazone)
  • metformin (metformin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Status: TERMINATED | Results posted: 2019-04-19